Literature DB >> 20031083

Socio-demographic and geographic analysis of overweight and obesity in Canadian adults using the Canadian Community Health Survey (2005).

J Slater1, C Green, G Sevenhuysen, J O'Neil, B Edginton.   

Abstract

Using the 2005 Canadian Community Health Survey, this study examined how overweight and obesity in Canadian adults are distributed across socio-demographic and geographic groupings. Overweight and obesity prevalence were modeled against socio-demographic indicators using Poisson regression and were assessed geographically using choropleth maps. The Gini coefficient was used to assess the distribution of prevalence across risk groups. The potential impacts of high risk versus population-based prevention approaches on the population prevalence of obesity were also examined. Of adults aged 25 to 64 years, 17% were obese and 53% were overweight or obese, with the highest proportions observed in older age groups, among those who were physically inactive, white or non-immigrant, with low educational levels, and living in the prairie and east coast regions. Recalculation of obesity rates under the different prevention scenarios demonstrated that population-based approaches could achieve a four-fold greater decrease in obesity cases than high risk approaches, highlighting the need for broader population strategies for obesity prevention in Canada.

Entities:  

Mesh:

Year:  2009        PMID: 20031083

Source DB:  PubMed          Journal:  Chronic Dis Can        ISSN: 0228-8699


  8 in total

1.  Recommendations for prevention of weight gain and use of behavioural and pharmacologic interventions to manage overweight and obesity in adults in primary care.

Authors:  Paula Brauer; Sarah Connor Gorber; Elizabeth Shaw; Harminder Singh; Neil Bell; Amanda R E Shane; Alejandra Jaramillo; Marcello Tonelli
Journal:  CMAJ       Date:  2015-01-26       Impact factor: 8.262

2.  The landscape of overweight and obesity in Icelandic adolescents: geographic variation in body-mass index between 2000 and 2009.

Authors:  I E Thorisdóttir; A L Kristjansson; I D Sigfusdottir; J P Allegrante
Journal:  J Community Health       Date:  2012-02

3.  Inequalities in neighborhood child asthma admission rates and underlying community characteristics in one US county.

Authors:  Andrew F Beck; Terri Moncrief; Bin Huang; Jeffrey M Simmons; Hadley Sauers; Chen Chen; Robert S Kahn
Journal:  J Pediatr       Date:  2013-03-22       Impact factor: 4.406

4.  How perceptions of community environment influence health behaviours: using the Analysis Grid for Environments Linked to Obesity Framework as a mechanism for exploration.

Authors:  L M Nieuwendyk; A P Belon; H Vallianatos; K D Raine; D Schopflocher; J C Spence; R C Plotnikoff; C I Nykiforuk
Journal:  Health Promot Chronic Dis Prev Can       Date:  2016-09       Impact factor: 3.240

5.  Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: a randomized controlled trial.

Authors:  C M Friedenreich; C G Woolcott; A McTiernan; T Terry; R Brant; R Ballard-Barbash; M L Irwin; C A Jones; N F Boyd; M J Yaffe; K L Campbell; M L McNeely; K H Karvinen; K S Courneya
Journal:  Int J Obes (Lond)       Date:  2010-09-07       Impact factor: 5.095

6.  Beyond weight: examining the association of obesity with cardiometabolic related inpatient costs among Canadian adults using linked population based survey and hospital administrative data.

Authors:  Neeru Gupta; Zihao Sheng
Journal:  BMC Health Serv Res       Date:  2021-01-11       Impact factor: 2.655

7.  Examining the association between work stress, life stress and obesity among working adult population in Canada: findings from a nationally representative data.

Authors:  Nigatu Regassa Geda; Cindy Xin Feng; Yamei Yu
Journal:  Arch Public Health       Date:  2022-03-29

8.  Neighbourhood walkability, leisure-time and transport-related physical activity in a mixed urban-rural area.

Authors:  Eric de Sa; Chris I Ardern
Journal:  PeerJ       Date:  2014-07-01       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.